ARCHIVES

DeVita Defends CHP Awards, Says Program Has High Priority

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979